JUA-19118-28819
3 vaccinations
8 coded responses
27 check-ins
8 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 207 / MD
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 1 — Moderna
-
2021-01-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
-
2021-01-29
Survey response — day 21, dose 1MedDRA: Fatigue — Feeling: FairFree text: Fatigue has been extremeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Dose 2 — Moderna
-
2021-02-05
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Swollen lymph nodes in axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-12
Health check-in — day 7, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-19
Survey response — day 14, dose 2MedDRA: Fatigue, Headache, Injection site pain, Myalgia, Nausea, Rash, Vomiting — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Soreness at the injection site, fatigue, nausea, headache, vomiting, muscle aches, rashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
-
2021-03-05
Survey response — day 28, dose 2MedDRA: Fatigue, Headache, Rash — Feeling: FairFree text: Pinpoint Rash bilaterally on arms and upper trunk, headache and fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Survey response — day 35, dose 2MedDRA: Dizziness, Fatigue, Feeling abnormal, Injection site pain — Feeling: FairFree text: Fatigue, dizziness/foggy, intermittent upper arm ache at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — day 42, dose 2MedDRA: Fatigue, Headache — Feeling: GoodFree text: Fatigue and headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-07
-
2021-08-06
Survey response — 6 months, dose 2MedDRA: Cough, Headache, Nasopharyngitis, Sinus congestion — Feeling: FairFree text: Cough, sinus congestion, headache (cold)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-19
Dose 3 — Moderna
- 2022-02-05
- 2022-02-18
- 2022-05-20
-
2022-11-19
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-11-19
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-11-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Moderna | |
| 2 | 2021-02-05 | Moderna | |
| 3 | 2021-11-19 | Moderna | No |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 3 — day 21, dose 1
Symptoms: Fatigue has been extreme
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes in axilla
Release 4 — day 14, dose 2
Symptoms: Soreness at the injection site, fatigue, nausea, headache, vomiting, muscle aches, rash
Release 5 — day 28, dose 2
Symptoms: Pinpoint Rash bilaterally on arms and upper trunk, headache and fatigue
Release 5 — day 35, dose 2
Symptoms: Fatigue, dizziness/foggy, intermittent upper arm ache at injection site
Release 5 — day 42, dose 2
Symptoms: Fatigue and headaches
Release 9 — 6 months, dose 2
Symptoms: Cough, sinus congestion, headache (cold)
Release 12 — 12 months, dose 3
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Sinus congestion | ✓ | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release